Cleared Traditional

K251377 - Magic InBra

K251377 is the FDA 510(k) clearance for Magic InBra by Medela AG. It is a Class 2 Obstetrics & Gynecology device (product code HGX) cleared through the Traditional 510(k) pathway after a 139-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2025
Decision
139d
Days
Class 2
Risk

K251377 is an FDA 510(k) clearance for the Magic InBra. Classified as Pump, Breast, Powered (product code HGX), Class II - Special Controls.

Submitted by Medela AG (Baar, CH). The FDA issued a Cleared decision on September 18, 2025 after a review of 139 days - within the typical 510(k) review window.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.5160 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Medela AG devices

Submission Details

510(k) Number K251377 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 02, 2025
Decision Date September 18, 2025
Days to Decision 139 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
21d faster than avg
Panel avg: 160d · This submission: 139d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HGX Pump, Breast, Powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.5160
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Consultant

Medela, LLC
Tiana Steinhoff

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - HGX Pump, Breast, Powered

All 128
Devices cleared under the same product code (HGX) and FDA review panel - the closest regulatory comparables to K251377.
Electric Breast Pump (HL-3060, F5113)
K252630 · Fimilla (Shanghai) Maternity & Baby Articles Co., Ltd. · Oct 2025
electric breast pump (FZ-P8)
K251977 · Ningbo Youhe Electrical Appliance Technology Co., Ltd. · Oct 2025
Hi bebe super (BT-150B)
K251512 · Bistos Co., Ltd. · Sep 2025
Momcozy Wearable Breast Pump (BP223)
K251394 · Shenzhen Root Innovation Technology Co., Ltd. · Sep 2025
Wearable Breast Pump (Model S33)
K251754 · Shenzhen TPH Technology Co., Ltd. · Sep 2025
Wearable Breast Pump (Model W6)
K250383 · Shenzhen TPH Technology Co., Ltd. · Aug 2025